Cleared Traditional

K030849 - AMNISURE FETAL MEMBRANES RUPTURE TEST MODEL FMRT1

K030849 is an FDA 510(k) clearance for AMNISURE FETAL MEMBRANES RUPTURE TEST M..., manufactured by N-Dia, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 322-day FDA review.

K030849 · N-Dia, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2004
Decision
322d
Days
Class 1
Risk

K030849 is an FDA 510(k) clearance for the AMNISURE FETAL MEMBRANES RUPTURE TEST MODEL FMRT1. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by N-Dia, Inc. (New York, US). The FDA issued a Cleared decision on February 2, 2004 after a review of 322 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all N-Dia, Inc. devices

FDA 510(k) Submission Details - K030849

510(k) Number K030849 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 2003
Decision Date February 02, 2004
Days to Decision 322 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
234d slower than avg
Panel avg: 88d · This submission: 322d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 437
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K030849.
LINICAL URIC ACID CALIBRATION VERIFIERS LEVELS A - E FOR OLYMPUS AU SYSTEMS
K040455 · Cliniqa Corporation · Mar 2004
A1C-CELLULAR
K040025 · Streck Laboratories, Inc. · Mar 2004
ELECSYS C-PEPTIDE CALCHECK
K040157 · Roche Diagnostics Corp. · Feb 2004
NOVA GLUCOSE CONTROL SOLUTIONS
K033433 · Nova Biomedical Corp. · Jan 2004
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBC IGM CONTROLS
K032993 · Ortho-Clinical Diagnostics, Inc. · Oct 2003
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-HBC CONTROLS
K033127 · Ortho-Clinical Diagnostics · Oct 2003